Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AcusensusASX:ACE -1.71%50 Days Sales Outstanding is 41.52 as of Dec. 2025, which is 8% below its 10-year median of 45.30. GuruFocus rates ASX:ACE with a GF Score™ of 50/100 and a GF Value™ of A$1.45 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 2,767 Software companies, Acusensus ranks better than 61.91% on this metric.
Acusensus's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$9.17 Mil. Acusensus's Revenue for the
six
months ended in Dec. 2025 was A$40.28 Mil.
Hence, Acusensus's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 41.52.
The historical rank and industry rank for Acusensus's Days Sales Outstanding or its related term are showing as below:
ASX:ACE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.76 Med: 45.3 Max: 50.75
Current: 50.75
During the past 4 years, Acusensus's highest Days Sales Outstanding was 50.75. The lowest was 34.76. And the median was 45.30.
ASX:ACE's Days Sales Outstanding is ranked better than 61.91% of 2767
companies
in the Software industry
Industry Median: 61.33
vs ASX:ACE: 50.75
Acusensus's Days Sales Outstanding
declined
from Dec. 2024 (52.36) to Dec. 2025 (41.52).
Acusensus (ASX:ACE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Acusensus Days Sales Outstanding Related Terms
Acusensus Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Acusensus's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ACE vs MSFT, ORCL, PLTR: Days Sales Outstanding Comparison
For the Software - Infrastructure subindustry, Acusensus's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acusensus Days Sales Outstanding vs Software Industry
For the Software industry and Technology sector, Acusensus's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Acusensus's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acusensus (ASX:ACE) has a Days Sales Outstanding of 41.52 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Acusensus and its competitors. This is near median its historical median of 45.30. Over the past decade, Acusensus' Days Sales Outstanding has ranged from 34.76 to 50.75. According to the industry distribution chart, Acusensus ranks #1054 out of 2767 companies in the Software industry, placing it in the top 38.1%.
Is Acusensus' Days Sales Outstanding too high?
Acusensus' current Days Sales Outstanding of 41.52 is near median its 10-year median of 45.30. Over the past 10 years, this metric has ranged from a low of 34.76 to a high of 50.75. The Software industry median Days Sales Outstanding is 61.33. Acusensus' value of 41.52 is 32.3% below this industry median. Based on the distribution chart, Acusensus ranks #1054 out of 2767 companies in the Software industry, which is above the industry midpoint. Overall, Acusensus has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acusensus' Days Sales Outstanding compare to MSFT and ORCL?
According to the Software industry distribution chart, Acusensus ranks #1054 out of 2767 companies for Days Sales Outstanding. This puts Acusensus in the upper half of its industry. The industry median Days Sales Outstanding is 61.33. Acusensus' value of 41.52 is 32.3% below this benchmark. Historically, Acusensus' own Days Sales Outstanding has ranged from 34.76 to 50.75 over the past decade. While the company's 10-year median is 45.30 vs. the industry median of 61.33, Acusensus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Software company?
The median Days Sales Outstanding among Software companies is 61.33, based on 2,767 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acusensus's current Days Sales Outstanding of 41.52 is 32.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Acusensus and its competitors. For the Software industry, the median Days Sales Outstanding is 61.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acusensus's current Days Sales Outstanding is 41.52, which is near median its own 10-year median of 45.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.45, compared to a current price of A$1.15 — trading 20.7% below its estimated fair value. The current Days Sales Outstanding is 41.52, which is near median its 10-year median of 45.30 and 32.3% below the Software industry median of 61.33. Acusensus' overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current Days Sales Outstanding is 41.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acusensus (ASX:ACE) Overvalued in 2026?
Based on GuruFocus' analysis, Acusensus stock appears to be undervalued.
The current stock price of A$1.15 is trading 20.7% below its estimated GF Value™ of A$1.45.
GuruFocus considers Acusensus to be Modestly Undervalued.
Key valuation signals for ASX:ACE:
Days Sales Outstanding: 41.52 (near median its 10-year median of 45.30)
GF Value™: A$1.45 vs. price of A$1.15 (20.7% below fair value)
Industry Position: 32.3% below the Software median (#1054 of 2767)
No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
50GF Score
Get the complete analysis for ASX:ACE
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACE has been successfully added to your 
